Biosensics
Clinical trials sponsored by Biosensics, explained in plain language.
-
Sensors track muscle disease at home in groundbreaking tech trial
Knowledge-focused Not yet recruitingThis study aims to see if wearable sensors and smartphone apps can effectively track the symptoms of myasthenia gravis (a muscle-weakening disease) at home. It will observe 25 people who are starting a new treatment, following them for 16 weeks. The goal is to gather detailed, re…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Can your smartphone track muscle weakness? new study aims to find out
Knowledge-focused Not yet recruitingThis study aims to see if wearable sensors and smartphone apps can reliably track the symptoms of myasthenia gravis (MG), a condition that causes muscle weakness. Over 12 months, 50 participants will wear activity sensors and complete digital speech and video tasks at home. The g…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Sensors track brain disease at home
Knowledge-focused Not yet recruitingThis study aims to test if small wearable sensors can accurately track movement and daily function in people with progressive supranuclear palsy (PSP) or Lewy body dementia. Researchers will have 60 participants wear sensors on their wrists, ankles, and chest during clinic tests …
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Wearable tech could revolutionize how doctors track devastating brain disease
Knowledge-focused Not yet recruitingThis study aims to test whether wearable sensors and digital apps can accurately track the progression of Huntington's disease, a serious inherited brain disorder. Over 12 months, 75 participants—some with Huntington's and some healthy—will wear sensors and complete digital tasks…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC
-
Wrist sensors and voice tests aim to map Dementia's progression
Knowledge-focused Not yet recruitingThis study aims to test if wearable sensors and computerized speech tests can reliably track the symptoms of frontotemporal dementia (FTD) and related disorders. Researchers will follow 20 patients for one year, using the devices at home between clinic visits every three months. …
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:21 UTC